Search

everythinglearnresearchcommunity

for

Search:↓

CK 15, follistatin, and Bmi-1 can help differentiate basal cell carcinoma from squamous cell carcinoma.

The tumor suppressor BRCA2 helps in cell division by bringing key proteins to the area where cells split.

Mohs micrographic surgery is effective for treating basal cell carcinoma on the eyelid, while radiotherapy has higher recurrence rates, and topical vitamin D3 may reduce and delay BCC formation in mice.

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

Scalp basal cell carcinoma in Asians is different from facial basal cell carcinoma, with unique features like being more common in younger people and having larger tumors.

Patients with central centrifugal cicatricial alopecia benefit from shared decision-making with their doctors.

Patients with central centrifugal cicatricial alopecia may have a higher risk of breast and colorectal cancer.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

CCCA mainly affects Black women and is linked to high-tension hairstyles, heating tools, chemical relaxants, and genetics.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Basal cell carcinomas may differentiate similarly to hair follicles and could be influenced by hair cycle-related treatments.

CCCA can affect both genders and all ages, and it has a genetic component.

Most people with basal cell carcinoma on their head or neck were 60-70 years old, and it often came back even after being fully removed, especially in certain areas and types.

Severe CCCA may be biologically and clinically different from milder forms.

Basal cell carcinoma mostly starts from cells in the upper skin layers, not hair follicle stem cells.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

Heat shock proteins help basal cell carcinoma grow by responding to inflammation signals.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

Surgical excision is the best treatment for SCC, but intralesional cidofovir might be a viable alternative.

A woman with both Cronkhite-Canada syndrome and myelodysplastic syndrome improved significantly with corticosteroid treatment.

Diagnosing and treating CCCA requires understanding multiple causes and using various diagnostic tools.

A new genetic variant causes BRESHECK syndrome by disrupting cell growth and stress response.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

IRS premature desquamation is not unique to CCCA and occurs in various scarring alopecias.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

CCCA is a common hair loss condition in African American women, often inherited and influenced by hairstyling, with unique scalp features detectable by special tools.

Albumin and prednisone improved symptoms in a woman with Cronkhite-Canada syndrome, revealing potential genetic causes.